
Keywords: CAv; commercial bothropic antivenom; CRelAb; relative concentration of antibody; CRelAv; relative concentration of antibody in the antivenoms; EDL; extensor digitorum longus muscle; Maxh; maximum reactivity between venom and antivenom; RCav; relative conc